Phenotype
|
Fish
|
Conditions
|
Figures
|
epidermal cell membrane ab1-llgl2 labeling spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell irregular spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell cdh1 expression increased amount, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
epidermal cell cdh1 expression spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
peridermal cell organelle membrane EGFP expression spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 1 ,
Fig 4
from Phatak et al., 2021
|
epidermal cell ab2-cdh1 labeling spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
peridermal cell regulation of cell adhesion process quality, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 1
from Phatak et al., 2021
|
epidermal cell ab1-llgl2 labeling spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
peridermal cell delamination increased frequency, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 1
from Phatak et al., 2021
|
epidermal cell ab1-llgl2 labeling increased amount, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell delamination cellular spatiotemporal quality, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
epidermal cell ab2-cdh1 labeling increased amount, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
peridermal cell epithelial structure maintenance decreased process quality, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 1
from Phatak et al., 2021
|
epidermal cell increased thickness, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
peridermal cell plasma membrane EGFP expression spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b
|
standard conditions
|
Fig 1 ,
Fig 4
from Phatak et al., 2021
|
epidermis cdh1 expression increased amount, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 3
from Phatak et al., 2021
|
epidermal cell delamination increased frequency, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 4 ,
Fig 5
from Phatak et al., 2021
|
epidermis cldne expression increased amount, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 3
from Phatak et al., 2021
|
epidermis cldn7b expression increased amount, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 3
from Phatak et al., 2021
|
epidermis grhl3 expression increased amount, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 3
from Phatak et al., 2021
|
epidermis dsc2l expression increased amount, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 3
from Phatak et al., 2021
|
epidermis oclna expression increased amount, abnormal
|
TU + MO1-myo5b
|
standard conditions
|
Fig 3
from Phatak et al., 2021
|
periderm cell population proliferation increased occurrence, abnormal
|
WT + MO1-myo5b
|
standard conditions
|
Fig. 5
from Sonal et al., 2014
|
epidermal basal stratum cell population proliferation increased occurrence, abnormal
|
WT + MO1-myo5b
|
standard conditions
|
Fig. 5
from Sonal et al., 2014
|
peridermal cell increased amount, abnormal
|
WT + MO1-myo5b
|
standard conditions
|
Fig. 5
from Sonal et al., 2014
|
cell lysosome increased accumulation periderm, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 2
from Sonal et al., 2014
|
peridermal cell apical plasma membrane decreased area, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 4
from Sonal et al., 2014
|
peridermal cell decreased size, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 4 ,
Fig. 5
from Sonal et al., 2014
|
cell vesicle increased accumulation periderm, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 2
from Sonal et al., 2014
|
peridermal cell cell projection membrane absent, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 4
from Sonal et al., 2014
|
cell endosome increased accumulation periderm, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 2
from Sonal et al., 2014
|
peridermal cell basolateral plasma membrane decreased area, abnormal
|
zf106Tg + MO1-myo5b
|
standard conditions
|
Fig. 4
from Sonal et al., 2014
|
epidermal cell delamination normal frequency, ameliorated
|
grhl3zf3707/zf3707 + MO1-myo5b
|
standard conditions
|
Fig 4
from Phatak et al., 2021
|
epidermal cell delamination cellular spatiotemporal quality, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
peridermal cell organelle membrane EGFP expression spatial pattern, ameliorated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 4
from Phatak et al., 2021
|
epidermal cell membrane ab1-llgl2 labeling spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell decreased thickness, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell ab1-llgl2 labeling spatial pattern, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell ab2-cdh1 labeling spatial pattern, ameliorated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
epidermal cell ab1-llgl2 labeling increased amount, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell cell division increased frequency, abnormal
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
peridermal cell plasma membrane EGFP expression spatial pattern, ameliorated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 4
from Phatak et al., 2021
|
epidermal cell irregular spatial pattern, exacerbated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 6
from Phatak et al., 2021
|
epidermal cell ab2-cdh1 labeling amount, ameliorated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
epidermal cell cdh1 expression amount, ameliorated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
epidermal cell cdh1 expression spatial pattern, ameliorated
|
zf106Tg/zf106Tg + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 7
from Phatak et al., 2021
|
epidermal cell delamination normal frequency, ameliorated
|
TU + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 4
from Phatak et al., 2021
|
epidermal cell delamination increased frequency, exacerbated
|
TU + MO1-myo5b + MO4-grhl3
|
standard conditions
|
Fig 5
from Phatak et al., 2021
|
periderm cell decreased amount, abnormal
|
WT + MO1-myo5b + MO2-tp63
|
standard conditions
|
Fig. 5
from Sonal et al., 2014
|
peridermal cell apoptotic process increased occurrence, abnormal
|
WT + MO1-myo5b + MO2-tp63
|
standard conditions
|
Fig. 5
from Sonal et al., 2014
|